<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="8217">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01891604</url>
  </required_header>
  <id_info>
    <org_study_id>jamesfriel2013</org_study_id>
    <nct_id>NCT01891604</nct_id>
  </id_info>
  <brief_title>Study the Safety and Efficacy of Probiotics Use in Premature Infants</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Manitoba</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Manitoba</source>
  <oversight_info>
    <authority>Canada: Ethics Review Committee</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prophylactic enteral probiotics may enhance clinical markers and biomarkers of preterm
      infants' health, and may also play a role in reducing NEC and associated morbidity.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <primary_completion_date type="Anticipated">August 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Intervention Model: Parallel Assignment</study_design>
  <primary_outcome>
    <measure>Calprotectin will be used to determine the effect for probiotics</measure>
    <time_frame>day1 and day30 of the observation</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Infant, Premature, Diseases</condition>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>breast milk with probiotic</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>breast milk</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  born with weightï¼œ1500 g

          -  hospitalized within 48 hours after birth

        Exclusion Criteria:

          -  present with evidence or suspicion of congenital intestinal obstruction

          -  perforation

          -  gastroschisis

          -  large omphalocele

          -  congenital diaphragmatic hernia

          -  major congenital heart defects
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>2 Days</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>June 2013</verification_date>
  <lastchanged_date>June 28, 2013</lastchanged_date>
  <firstreceived_date>June 26, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Manitoba</investigator_affiliation>
    <investigator_full_name>Dr. James Friel</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Infant, Premature, Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
